PROVIREX’s error-free genome-editing precision technology with recombinases. Precisely cutting out proviruses to halt HIV infection. This technology is being tested in a clinical phase Ib/IIa trial.

Exhibitor
PROVIREX Genome Editing Therapies GmbH

My German Pavilion

  • Manage your personal profile here and enter your desired business contacts to German companies
  • Keep an eye on the trade fairs, German exhibitors and products that are of interest to you
  • Receive an e-mail notification on relevant upcoming German trade fair presentations
Sign up now